Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/366586d2-092c-45d6-ad58-48b363f0a023/

EXEL

Exelixis Inc
Chart
$52.70
Latest Week 2026-06-05
HealthcareBiotechnologyLARGE
Snapshot 2026-06-07 · 0.0w · Fresh
0.51
OS Score
16.0%
Value
95.0%
Quality
68.0%
Momentum
6/9
F-Score
0.390
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
Yes
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
16.0%ile
P/E
16.9×
P/S
5.9×
P/B
7.3×
E/P
0.0592
FCF Yield
0.067
EBITDA/EV
0.072
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
85.00000000
/100 — 1=cheapest
VC2 (Trending Value)
86.00000000
/100
VC3 (Buyback)
86.00000000
/100
FCF yield of 6.7% is strong — the business generates significant free cash relative to price. VC2 score of 86.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
95.0%ile
ROE
0.431
ROA
0.321
Net Margin
0.351
Op Margin
0.408
GPA
0.883
D/E
0.34
Current
3.26
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.033
Earn Growth
0.295
Stability
0.235
lower=better
Accruals
-0.035
lower=better
5yr Consist
Yes
ROE of 43% is exceptional. Conservative balance sheet with D/E of 0.34.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
68.0%ile
6M Return
18.8%
12M Return
22.5%
12-1 Mom
11.9%
Risk-Adj
0.36
Vol 252d
33.2%
Vol 60d
62.1%
↑ Expanding
Max DD 12M
-19.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (62%) is expanding vs long-term (33%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.51
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
5.6%
Sector Quality %ile
95.8%
P/E z-score
-0.16
P/B z-score
0.19
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Quality at a Premium
High quality (95th) but expensive (16th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (62%) significantly exceeds 252-day (33%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
42.0% avg (7 factors)
Quality
A
95.7% avg (8 factors)
Momentum
C
50.6% avg (4 factors)
Risk
B
61.3% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.510—0—
Value %ile0.160—1—
Quality %ile0.950—1—
Momentum %ile0.680—0—
F-Score6.000—0—
Confidence0.970—1—
Volatility0.332—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
16.90
Earnings Yield (E/P)
0.0592
Price / Sales
5.93
Price / Book
7.28
Price / Cash Flow
15.24
FCF Yield
6.7%
EBITDA / EV
7.2%
Sales Yield (1/P·S)
0.1714
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
43.1%
Return on Assets
32.1%
Net Margin
35.1%
Operating Margin
40.8%
Gross Profit / Assets
Novy-Marx GPA
88.3%
Debt / Equity
0.34
Current Ratio
3.26
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.035
MomentumPrice trend strength over different horizons
6M Return
18.8%
12M Return
22.5%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
11.9%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.36
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
3.3%
Earnings Growth (YoY)
29.5%
Earnings Stability (CV)
Lower = more stable
0.235
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
6
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
85
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
86
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
86
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
Yes
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity